← FDA Drug Approvals (Drugs@FDA)

BUPRENORPHINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2018-11-20

Drug application

FDA Application #

ANDA204937

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUPRENORPHINE

Generic name

BUPRENORPHINE

Active ingredients

BUPRENORPHINE

Dosage form

FILM, EXTENDED RELEASE

Route

TRANSDERMAL

Marketing status

Prescription

Sponsor

WATSON LABS TEVA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2018-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown